State of Tennessee, Department of Treasury
FATE icon

State of Tennessee, Department of Treasury’s Fate Therapeutics FATE Stock Holding History

State of Tennessee, Department of Treasury’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$108K Hold
90,000
– – ﹤0.01% 1693
2025
Q4 		$107K Buy
+90,000
New +$108K ﹤0.01% 1705

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State of Tennessee, Department of Treasury's FATE Position: Q1 2026 in Review

State of Tennessee, Department of Treasury held its Fate Therapeutics (FATE) position steady in Q1 2026 at 90,000 shares worth $108K. The position accounts for ﹤0.01% of the portfolio, ranked #1693.

State of Tennessee, Department of Treasury first reported a position in FATE in Q4 2025 and has held it in 2 quarters since. 158 funds tracked by Wall St. Rank hold FATE as of Q1 2026.

  • State of Tennessee, Department of Treasury held 90,000 shares of Fate Therapeutics worth $108K as of Q1 2026.
  • State of Tennessee, Department of Treasury left its Fate Therapeutics share count unchanged in Q1 2026.
  • Fate Therapeutics made up ﹤0.01% of State of Tennessee, Department of Treasury's portfolio in Q1 2026, its #1693 holding.
  • State of Tennessee, Department of Treasury first reported a position in Fate Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 158 funds tracked by Wall St. Rank held Fate Therapeutics as of Q1 2026.

Based on State of Tennessee, Department of Treasury's 13F filing for Q1 2026, filed 15 May 2026.